Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 3/A Insider 3/A
  2. 4 Open-market buy Director bought 400,000 shares at $19.00 ($7,600,000)
  3. 4 Open-market buy 10% owner bought 853,000 shares at $19.00 ($16,207,000)
  4. 4 Open-market buy 10% owner bought 975,000 shares at $19.00 ($18,525,000)
  5. 4 Open-market buy Director bought 975,000 shares at $19.00 ($18,525,000)
  6. 4 Open-market buy Director bought 3,000 shares at $19.00 ($57,000)
  7. 4 Open-market buy Director bought 850,000 shares at $19.00 ($16,150,000)
  8. 4 Open-market buy VP Fin & Chief Acct Officer bought 3,000 shares at $19.00 ($57,000)
  9. 4 Open-market buy Chief Financial Officer bought 3,000 shares at $19.00 ($57,000)
  10. 4 Conversion Chief Business Officer acquired 10,529 shares (conversion)
  11. 4 Conversion President and CEO acquired 27,292 shares (conversion)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 11 · 213 filings